September 18, 2019
Mitsubishi Tanabe Pharma said on September 17 that it has entered into a license agreement with Daiichi Sankyo for the commercialization rights for an intravenous infusion formulation of its amyotrophic lateral sclerosis (ALS) treatment edaravone in Brazil. Mitsubishi Tanabe also...read more